BUSINESS● LOW3h ago · Sep 2, 2026, 4:47 PM
Novartis and Alteogen ink injectable drug delivery deal worth up to $3.2B
Seeking Alpha Tech · global
Novartis and Alteogen have formalized an agreement for injectable drug delivery, a deal that could be worth up to $3.2 billion. This partnership focuses on advancing pharmaceutical solutions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS8m agoSA analyst warns the market rebound may mask stagflation risksSeeking Alpha TechBUSINESS11m agoEl Jalapeño: US, Mexico near trade war over right to misname European cheeseMexico News DailyBUSINESS15m agoNo uniformity in food prices as traders go their own wayThe HinduBUSINESS17m agoActivist Elliott builds stake in Deutsche Telekom - BloombergSeeking Alpha Tech